Loading stock data...
Last Updated: 10 Mar 2026, 03:30:03 PM (IST)

Anthem Biosciences Ltd.

NSE: ANTHEM

NSE
670.15 10.00 (1.51%)

Prev Close

660.15

Open Price

674

Volume

141,357

Today Low / High

665.1 / 679.9

52 WK Low / High

579.15 / 873.5

Range

637 - 704

Currently, the stock is trading on the National Stock Exchange (NSE). The stock price stands at 670.15, with a change of 10 (1.51481%). The expected target range on the NSE is between 637 - 704. The stock is trending upwards on the NSE, which could present a good opportunity for potential investors.

02 Mar 653.05 5.26%
27 Feb 700.05 0.09%
26 Feb 711.00 -1.15%
25 Feb 700.00 0.51%
24 Feb 699.00 -0.48%
23 Feb 682.65 1.94%
20 Feb 697.55 -2.42%
19 Feb 686.40 1.31%

Anthem Biosciences Ltd. Graph

Anthem Biosciences Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Anthem Biosciences Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 670.15, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 670.15 676.85 609.17 - 744.54
683.55 546.84 - 820.26
690.25 483.18 - 897.33
Bearish Scenario 670.15 663.45 597.10 - 729.79
656.75 525.40 - 788.10
650.05 455.03 - 845.06

Overview of Anthem Biosciences Ltd.

ISIN

INE0CZ201020

Industry

Biotechnology

Vol.Avg

286,813

Market Cap

386,122,101,177

Last Dividend

0

Official Website

Visit Website

IPO Date

2025-07-21

DCF Diff

617.07

DCF

70

Financial Ratios Every Investor Needs

Stock Rating Details for ANTHEM

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 1,844.55 Cr 743.91 Cr 1,100.64 Cr 0.5967 19.52 Cr 9.03 Cr 592.15 Cr 451.26 Cr 8.04 756.26 Cr 0.2446

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 316.14 Cr 2,807.58 Cr 397.72 Cr 2,409.8640 Cr 113.32 Cr -202.83 Cr 340.43 Cr 1,007.43 Cr 0.00 Cr 0.93 Cr 0.00 Cr 326.2330 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 418.3360 Cr -152.1130 Cr -133.6000 Cr 103.6670 Cr 132.6230 Cr 316.9810 Cr -314.5290 Cr 656.8680 Cr -123.8070 Cr 0.0000 Cr -129.0870 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 423.15 Cr 247.60 Cr 175.55 Cr 0.4149 122.67 Cr 92.82 Cr 1.65 165.36 Cr 0.2193
2025-09-30 550.03 Cr 223.36 Cr 326.67 Cr 0.5939 184.40 Cr 173.43 Cr 3.09 266.13 Cr 0.3153
2025-06-30 540.21 Cr 329.36 Cr 210.85 Cr 0.3903 165.05 Cr 135.79 Cr 2.42 214.30 Cr 0.2514
2025-03-31 483.20 Cr 176.85 Cr 306.35 Cr 0.6340 175.45 Cr 82.62 Cr 1.48 208.94 Cr 0.1710
2024-09-30 524.96 Cr 187.84 Cr 337.11 Cr 0.6422 175.24 Cr 161.93 Cr 2.88 223.08 Cr 0.3085

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 503.83 Cr 596.30 Cr 1,100.13 Cr 577.34 Cr 185.76 Cr 2,184.10 Cr 1,029.47 Cr 3,284.30 Cr 531.75 Cr
2025-03-31 316.14 Cr 416.14 Cr 732.28 Cr 459.91 Cr 340.43 Cr 1,736.72 Cr 1,007.43 Cr 2,807.58 Cr 397.72 Cr
2024-09-30 214.35 Cr 461.12 Cr 675.47 Cr 486.07 Cr 363.87 Cr 1,684.43 Cr 914.52 Cr 2,692.51 Cr 488.14 Cr
2024-03-31 183.86 Cr 459.07 Cr 642.93 Cr 490.64 Cr 211.35 Cr 1,481.55 Cr 837.71 Cr 2,398.11 Cr 473.46 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
No quarterly financial cash flow statement data available.

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹395.80 ₹502,336,973,043.00 ₹3,554,697.00
Anthem Biosciences Ltd. ANTHEM ₹670.15 ₹376,432,537,248.00 ₹141,357.00
Piramal Pharma Limited PPLPHARMA ₹155.37 ₹205,611,590,763.00 ₹1,450,331.00
Onesource Specialty Pharma Ltd. ONESOURCE ₹1,473.90 ₹168,940,186,680.00 ₹277,137.00
Syngene International Limited SYNGENE ₹409.30 ₹164,437,005,191.00 ₹675,182.00
Concord Biotech Limited CONCORDBIO ₹1,197.20 ₹125,246,519,429.00 ₹100,555.00
Jubilant Ingrevia Limited JUBLINGREA ₹570.75 ₹90,184,712,614.00 ₹363,355.00
Blue Jet Healthcare Limited BLUEJET ₹376.10 ₹65,240,346,343.00 ₹357,325.00
Supriya Lifescience Limited SUPRIYA ₹604.80 ₹48,675,997,440.00 ₹105,837.00
Zota Health Care Limited ZOTA ₹1,176.70 ₹35,692,435,139.00 ₹47,409.00
Dishman Carbogen Amcis Limited DCAL ₹164.51 ₹25,792,386,958.00 ₹431,232.00

Key Executives

Chief Scientific Officer & Executive Director
Ganesh Sambasivam

Gender: Not Specified

Year Born: 1965

Founder, Chairman, MD & Chief Executive Officer
Ajay Bhardwaj

Gender: male

Year Born: 1960

Vice President
Ishaan Bhardwaj

Gender: male

Year Born:

General Counsel
K. Ramakrishnan

Gender: male

Year Born:

Co-Founder, Chief Operating Officer & Executive Director
K. Ravindra Chandrappa

Gender: male

Year Born: 1966

Vice President & Head of Operations of Specialty Ingredients
Malay Jiban Barua

Gender: male

Year Born: 1968

Chief Financial Officer
Mohammed Gawir Baig

Gender: male

Year Born:

Vice President of Marketing
Rupesh N. Kinekar

Gender: male

Year Born:

Vice President of Sales
Satish Sharma

Gender: male

Year Born:

Company Secretary & Compliance Officer
Divya Prasad

Gender: female

Year Born:

FAQs about Anthem Biosciences Ltd.

Who is the CEO of the company?

The CEO is Ajay Bhardwaj.

What is the current market price of the stock?

The current price is ₹687.40.

What is the 52-week price range?

The range is ₹579.15-873.5.

What is the market capitalization of the company?

The market capitalization is ₹38,612.21 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 79.65.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Anthem Biosciences Ltd. (ISIN: INE0CZ201020) is a leading Biotechnology in India. With a market capitalization of ₹38,612.21 crores and an average daily volume of 286,813 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.